Two months have passed since the first corona19 confirmed in Korea. More than 90 people have died in Korea alone, and more than 8,700 people have died worldwide. Development of vaccines and treatments is only slow. Pharmaceutical companies complain that regulation is not easy to speed up. Looking at the current regulations for the development of new drugs, there is a 'priority screening rule' in the pandemic of infectious diseases, but it is not properly followed. In addition, it is a matter of notice that this regulation is not a law, and a deadline for examination is not set. To address this problem, a so-called 'quick screening' legislation was proposed two years ago, but it is still pending.

In the case of an emergency, a drug dispenser that can obtain drugs through a vending machine has changed its regime three times, but it has not been commercialized because of regulations related to the pharmacist law. A year ago, I knocked on the door of the so-called 'ICT regulation sandbox', which releases regulations for a certain period of time, but related ministries remain silent. A company that started a delivery service business by taxi two years ago is also in danger of spending hundreds of millions of won on development. This is because there are no laws related to the delivery of taxis, but related departments are delaying approval of the business, saying that there may be a conflict between the shipping companies.

"Regulation is a trap. I will never manufacture again in Korea."

Ki-Joo Lee, who received a patent five years ago, has recently closed the garment filling business. It was the first in the world to develop a filler that blends wool and polyester, but it has not been approved for production. This is because of the notice on the display of fiber mixing ratio. According to the Swiss Institute of International Affairs, Korea's corporate regulation ranking is ranked 50th out of 63 countries in the world. There are no alternatives for entrepreneurs who fold business because they are in a hurry due to regulations.

This week, <Newstory> focused on the regulatory conditions and solutions to prevent the development of new technologies and industries, including the development of Corona19 treatments.

(Report: Park Heung-ro / Video coverage: Kim Seong-il / Writer: Lee Eun-ju / Assistant writer: Sang-hee Do)